COPENHAGEN, Denmark and MUNICH, Sept. 17, 2024 /PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS) ...
Dr Simon Agwale is the chief executive officer, ofInnovative Biotech Nigeria and Innovative Biotech USA. He also chairs the ...